Gedeon Richter to acquire Estetra and Neuralis from Mithra Pharmaceuticals for €175m.

Gedeon Richter, a European multinational pharmaceutical and biotechnology company, agreed to acquire pharmaceutical companies Estetra and Neuralis from Mithra Pharmaceuticals, a pharmaceutical company, for for €175m. “Acquiring Estetrol represents an outstanding strategic opportunity for Richter in one of its core therapeutic areas. I look forward to taking advantage of future synergies between the scientific team about to join Richter and our existing development, manufacturing and marketing platform paving the way to fulfil our target of becoming the leading European player in the field of WHC by the end of this decade," Gábor Orbán, Gedeon Richter CEO.